Skip to main content

DSM buys Amyris F&F ingredients

DSM has agreed to acquire the biobased flavour and fragrance (F&F) intermediates business of synthetic biotechnology company Amyris. This comprises seven products, of which four are “already generating meaningful sales”, two newly launched and one under development. They will be added to the DSM’s Personal Care & Aroma Ingredients activities, extending its offer to the F&F and cosmetics industries.

KD Pharma buys RohnerChem site

German CDMO KD Pharma, which is one of the world’s largest producers of omega-3 fatty acids has acquired the assets of former CDMO RohnerChem at Pratteln, near Basel, Switzerland (pictured), and hired some of the former team. Terms were not disclosed.

KD said that it aims to become an even bigger player and that the site’s “unique chemical processes and technological capabilities” enabled it “to manufacture difficult, multi-step pharmaceutical intermediates and APIs. This is a natural fit with our strategy.”

Lanxess enters battery chemistry

Lanxess has announced that it will be entering the battery chemistry business from 2022. It will produce electrolyte formulations for lithium-ion batteries for China’s Guangzhou Tinci Materials Technology using a plant operated by Saltigo in Germany. Further details were not disclosed.

Archroma, Huntsman in textile alliances

Archroma and Huntsman Textile Effects have both announced alliances in textile technology. The former has joined Jeanologia to launch the Pad-Ox G2 Cold dyeing process, while the latter has formed a strategic partnership with Sciessent in antimicrobial and odour-control technology.

Isochem owner buys Copperhead

New Jersey-based PMC Group International, a diversified manufacture of chemicals and pharmaceuticals, has acquired Cobra Investments Management from a consortium of previous owners. This includes Copperhead Chemical, which has a 350-hectare site at Tamaqua, Pennsylvania. Terms were not disclosed.

New R&D centre for Kemira

Kemira and its pension fund, Neliapila, have signed a pre-agreement and lease agreement with a consortium of Ahlström Capital, Kirkon Eläkerahasto and Aktia Life Insurance. Under this, they will build a new research centre for Kemira as part of the Green Chemistry Park within a 5.5-hectare site at Espoo, near Helsinki in Finland.

Atotech opens in China and India

Within the space of ten days in mid-March, Atotech announced that its new production site in China and its R&D centre are both fully operational. The company, which is based in Berlin, specialises in advanced electroplating. These developments bring its total network of sites to 17, including eight in Asia.

Subscribe to Current issue

Chem UK 2021 advert banner